CADASIL – Life with Disease

Go back

CADASIL is a rare inherited condition that affects the blood vessels in the brain, causing them to thicken and block blood flow. While symptoms and progression vary widely between individuals, understanding what to expect can help patients and families prepare for the journey ahead and make informed decisions about care and support.

Prognosis: What to Expect Over Time

Understanding the outlook for CADASIL can feel overwhelming, but knowing what lies ahead helps patients and families plan and find support. The progression of CADASIL is typically slow, unfolding over many years, but the journey is different for everyone. This variability means that while some people remain relatively well into their seventies, others may experience symptoms and disability much earlier in life.[1][19]

Most people with CADASIL begin to notice symptoms between the ages of 20 and 40, although signs can appear in childhood or not emerge until later in life. Common early symptoms include migraine headaches with aura (sensory disturbances like visual changes or tingling) and transient ischemic attacks, also called TIAs or ministrokes. As the years pass, many individuals experience multiple strokes that gradually affect thinking and memory. By age 65, most people with CADASIL will have developed cognitive impairment (reduced ability to think, remember, or make decisions) or dementia (severe decline in mental abilities that interferes with daily life).[1][5]

The disease typically leads to disability around age 58, as strokes and progressive damage to the brain’s white matter accumulate over time.[7] This disability can manifest as difficulty walking, problems with balance, muscle weakness, or profound cognitive decline. Some individuals become dependent on others for daily care as the disease advances. It’s important to understand that these are general patterns — individual experiences can differ significantly based on genetic factors, lifestyle choices, and other health conditions.

⚠️ Important
The severity of CADASIL varies widely even within the same family. Researchers have found that common risk factors such as smoking and high blood pressure can make strokes occur earlier and worsen the disease more rapidly. This means that while you cannot change the genetic mutation, you can influence how the disease progresses by controlling these modifiable risk factors.[19]

Natural Progression Without Treatment

If CADASIL is left unaddressed and risk factors are not managed, the disease follows a predictable but variable pattern of worsening over decades. The condition starts with changes in the brain’s small blood vessels long before symptoms appear. These blood vessel walls gradually thicken as abnormal protein accumulates, eventually blocking the normal flow of blood to brain tissue. This process damages the protective covering of nerves called myelin and causes small areas of tissue death beneath the brain’s outer layer.[4][13]

In the early stages, many individuals experience migraine headaches, often accompanied by aura. These migraines can be severe and disabling on their own. As blood flow problems worsen, small strokes begin to occur, sometimes without obvious symptoms at first. These are called silent strokes because they don’t cause immediately noticeable problems, but they accumulate damage over time. Eventually, larger or more numerous strokes lead to visible symptoms like weakness on one side of the body, difficulty speaking, or problems with coordination.[4]

Over time, repeated strokes and ongoing damage to the white matter of the brain lead to progressive decline in thinking abilities. Memory problems become more noticeable, and individuals may struggle with planning, problem-solving, and attention. Mood changes often accompany these cognitive difficulties — depression, apathy (lack of interest or motivation), and anxiety are common. Some people develop changes in personality or behavior that can be distressing for both the individual and their loved ones.[1][5]

As the disease advances further without intervention to manage risk factors, walking becomes increasingly difficult. Some people develop a condition called gait apraxia, where the brain’s ability to coordinate walking is disrupted, leading to an unsteady, wide-based walk or shuffling steps. Eventually, many individuals progress to subcortical dementia, characterized by slowed thinking, memory loss, and difficulty with complex tasks. In advanced stages, some people develop difficulty controlling facial muscles and speaking, a condition called pseudobulbar palsy, and may lose bladder control.[4][19]

Possible Complications

CADASIL can lead to a range of complications beyond the expected strokes and cognitive decline. One particularly serious complication is acute encephalopathy, a sudden episode of confusion or altered consciousness that can progress to coma. This medical emergency requires immediate attention and can be frightening for both patients and families.[1]

Another important complication involves small areas of bleeding in the brain called cerebral microbleeds. These occur because the disease damages blood vessels, making them fragile and prone to leaking. The presence of these microbleeds increases the risk of larger brain hemorrhages, especially if someone takes blood-thinning medications. This creates a difficult situation for doctors and patients: aspirin and similar medications might help prevent strokes caused by blood clots, but they also increase the risk of dangerous bleeding. As a result, the use of antiplatelet agents in CADASIL remains controversial and must be carefully considered for each individual.[8][11]

Seizures can develop as a complication of CADASIL, though they are less common than strokes and migraines. When seizures do occur, they require treatment with antiseizure medications. Some individuals experience vision problems as the disease affects blood flow to parts of the brain responsible for processing visual information. Others develop symptoms similar to Parkinson’s disease, including slow movements and tremors, a condition called parkinsonism.[1]

Mental health complications deserve special attention. Depression is extremely common in CADASIL and can be severe. The combination of physical disability, cognitive decline, and the emotional burden of living with a progressive genetic disease creates significant psychological strain. Some individuals experience bipolar disorder or profound apathy that makes it difficult to engage in rehabilitation or self-care. These psychiatric complications require active treatment, as they significantly affect quality of life and can worsen functional decline.[1][6]

In rare cases, CADASIL can present with unusual complications. There have been reports of individuals developing symptoms resembling schizophrenia or other forms of psychosis. Some people experience rapid onset of vertigo (sensation of spinning), severe nausea and vomiting, and abnormal walking patterns. These varied presentations can make diagnosis challenging and may lead to misdiagnosis before CADASIL is properly identified.[4]

Impact on Daily Life

Living with CADASIL affects virtually every aspect of daily life, from the most basic physical activities to complex social interactions and professional responsibilities. The physical limitations that develop over time can be particularly challenging. After strokes, many people experience weakness or numbness on one side of the body, making everyday tasks like dressing, bathing, or preparing meals more difficult. Walking problems may develop even without obvious strokes, as damage to the brain’s white matter disrupts coordination and balance. This can make simple activities like climbing stairs, carrying groceries, or moving around the house feel exhausting and dangerous.[5]

Cognitive changes profoundly affect how people function at work, manage household responsibilities, and maintain independence. Memory problems might start subtly — forgetting appointments, losing track of conversations, or misplacing items — but can progress to the point where individuals need reminders for basic daily routines. Difficulty with planning and problem-solving makes it hard to organize tasks, follow recipes, or manage finances. Slowed thinking means that activities that once felt automatic now require intense concentration and more time.[5][18]

The emotional toll of CADASIL extends beyond depression and mood changes. Many people struggle with frustration and grief as they lose abilities they once took for granted. The unpredictability of strokes creates constant anxiety — not knowing when the next event might occur or how severe it will be. For individuals who develop CADASIL relatively young, the disease disrupts career plans, financial stability, and family goals. Parents worry about passing the condition to their children and feel guilt about this genetic inheritance.[17][18]

Social relationships often suffer as CADASIL progresses. Cognitive difficulties can make conversations harder to follow, leading people to withdraw from social gatherings. Physical limitations may prevent participation in activities that once brought joy and connection — hiking with friends, playing with grandchildren, or attending community events. Some individuals experience personality changes or behavioral problems that strain relationships with family and friends. The need for increasing assistance with daily activities can shift relationship dynamics, turning spouses into caregivers and creating stress in marriages.[5]

Migraine headaches, which affect many people with CADASIL, add another layer of difficulty to daily life. These are not ordinary headaches but severe, disabling episodes that can last hours or days. During an attack, sensitivity to light and sound may force someone to retreat to a dark, quiet room, missing work, social events, or family time. The unpredictability of migraines makes planning difficult and can lead to missed appointments or canceled commitments.[5]

Employment becomes increasingly challenging as CADASIL progresses. Cognitive difficulties affect job performance, especially in positions requiring sustained attention, multitasking, or complex decision-making. Frequent medical appointments, rehabilitation sessions, and unpredictable symptoms make it hard to maintain a regular work schedule. Many people eventually need to reduce their hours, change to less demanding positions, or stop working altogether, creating financial strain and loss of professional identity.[18]

Despite these challenges, many people with CADASIL find ways to adapt and maintain quality of life. Keeping detailed notes and using calendars or smartphone reminders helps compensate for memory problems. Staying physically active within one’s abilities can slow functional decline and improve mood. Maintaining social connections, even if in modified forms like phone calls instead of in-person visits, protects against isolation. Seeking treatment for depression and other mood problems can significantly improve daily functioning. Many individuals find that focusing on what they can still do, rather than what they’ve lost, helps maintain a sense of purpose and well-being.[15]

Support for Families: Understanding Clinical Trials and Research

For families affected by CADASIL, understanding the role of clinical trials and research offers both hope and a way to contribute to progress against this disease. Currently, there is no cure or proven treatment that can stop or reverse the underlying blood vessel damage in CADASIL. However, researchers around the world are actively studying the disease to understand how the genetic mutation causes symptoms and to develop therapies that might slow or prevent progression.[1][6]

Clinical trials are research studies that test new treatments or approaches in people. For CADASIL, these studies might investigate medications that could protect blood vessels, reduce stroke risk, or improve cognitive function. Some research focuses on better understanding how lifestyle factors and existing medications affect disease progression. Other studies work to identify additional genes that might influence disease severity, which could lead to new therapeutic targets. While participating in research doesn’t guarantee personal benefit, it advances knowledge that will help future generations.[6]

Families can support their loved ones in considering research participation in several ways. First, help gather complete medical records, including brain imaging results, genetic testing reports, and documentation of symptoms over time. This information is often needed when applying for clinical trials. Second, assist with researching available studies. Major research institutions studying CADASIL often maintain lists of active clinical trials on their websites or through patient advocacy organizations. The National Institutes of Health also maintains a database of clinical trials that can be searched by disease name.[1]

When evaluating whether a clinical trial might be appropriate, families should help their loved one understand what participation involves. This includes learning about the study’s purpose, what treatments or procedures will be used, how long the study lasts, and what risks and potential benefits exist. Clinical trials have strict criteria about who can participate, based on factors like age, disease stage, other health conditions, and sometimes genetic mutation type. Families can help by honestly assessing whether their loved one meets these criteria and can manage the demands of participation.[6]

Practical support is crucial if someone decides to participate in research. Clinical trials often require frequent visits to research centers, which may involve travel to specialized medical centers. Families can help with transportation, accommodation arrangements, and attending appointments. Some studies require keeping detailed diaries of symptoms or taking medications at specific times — support with these tasks can make participation more manageable. Emotional support matters too, as being in a clinical trial can be stressful, especially if the hoped-for benefits don’t materialize or if side effects occur.

Beyond clinical trials, families can support research by helping their loved one join disease registries. These are databases that collect information about people with specific conditions to help researchers understand disease patterns and identify potential study participants. Some registries simply track basic information about symptoms and disease progression, while others involve periodic surveys or optional sharing of medical records. Participation in registries helps researchers design better studies and understand CADASIL more fully, even if someone isn’t eligible for or interested in active clinical trials.[5]

⚠️ Important
Research participation is always voluntary, and individuals can withdraw from studies at any time without affecting their regular medical care. Families should ensure their loved one understands this and feels empowered to make their own decisions about participation. The goal is to support informed choice, not to pressure someone into research they’re uncomfortable with.

Families can also stay informed about research progress by following reputable organizations that focus on CADASIL and related conditions. These organizations often share news about research breakthroughs, new clinical trials opening for enrollment, and advances in understanding the disease. They may also provide opportunities for families to connect with researchers through webinars, patient conferences, or educational materials. This knowledge helps families have informed conversations with healthcare providers and make better decisions about care.[15]

For some families, contributing to research takes a more personal form. Some individuals with CADASIL choose to donate their brain tissue for research after death. This allows scientists to study the disease at the cellular and molecular level in ways that aren’t possible during life, potentially leading to important discoveries. While this is a deeply personal decision, families who support this choice help advance understanding of CADASIL in a profound way.

Finally, families should remember that supporting someone through life with CADASIL involves balancing hope for future treatments with realistic acceptance of current limitations. Research moves slowly, and promising early results don’t always translate into available treatments. Maintaining perspective while staying engaged with research developments helps families navigate the emotional complexity of living with a currently incurable genetic disease.

💊 Registered drugs used for this disease

Based on the available information, there are no drugs specifically registered for treating CADASIL itself. However, several medications are used to manage symptoms and reduce risk factors:

  • Aspirin – A blood-thinning medication sometimes used to reduce the risk of recurrent strokes, though its use in CADASIL must be carefully considered due to bleeding risks
  • Clopidogrel – An alternative antiplatelet medication to aspirin for stroke prevention
  • Triptans (e.g., Imigran/Sumatriptan) – Medications used to treat acute migraine attacks when they occur
  • Acetazolamide – May help prevent migraines in some CADASIL patients
  • Valproic acid – Has shown efficacy for migraine prevention in CADASIL
  • Antidepressants – Standard medications used to treat depression, which is common in CADASIL patients
  • Antiseizure medications – Used when seizures occur as a complication of the disease

Ongoing Clinical Trials on CADASIL

  • Using [18F]DED PET imaging to study brain changes in patients with Alzheimer’s disease, CADASIL, and other forms of dementia.

    Not yet recruiting

    1 1
    Investigated drugs:
    Spain

References

https://www.ninds.nih.gov/health-information/disorders/cadasil

https://www.alzheimers.org.uk/about-dementia/types-dementia/cadasil

https://www.cuh.nhs.uk/patient-information/cadasil-a-guide-for-patients-and-families/

https://en.wikipedia.org/wiki/CADASIL

https://brainfoundation.org.au/disorders/cadasil/

https://www.brainfacts.org/diseases-and-disorders/neurological-disorders-az/diseases-a-to-z-from-ninds/cadasil

https://www.ncbi.nlm.nih.gov/books/NBK470293/

https://emedicine.medscape.com/article/1423170-overview

https://www.ninds.nih.gov/health-information/disorders/cadasil

https://pmc.ncbi.nlm.nih.gov/articles/PMC11221192/

https://emedicine.medscape.com/article/1423170-treatment

https://www.cuh.nhs.uk/patient-information/cadasil-a-guide-for-patients-and-families/

https://www.cedars-sinai.org/health-library/diseases-and-conditions/c/cadasil-carasil.html

https://www.cambridgestroke.com/istheretreatmentforcadasil.php

https://vascern.eu/news/cadasil-dos-and-donts-for-patients-factsheet-now-available/

https://www.cuh.nhs.uk/patient-information/cadasil-a-guide-for-patients-and-families/

https://curecadasil.org/patient-stories/

https://www.brainandlife.org/articles/living-with-rare-disease-cadasil

https://www.cambridgestroke.com/faqs.php

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

Why do some people with CADASIL stay healthy into their seventies while others develop symptoms in their thirties?

The severity of CADASIL varies widely even within the same family, and researchers don’t fully understand why. Common stroke risk factors like smoking and high blood pressure make symptoms appear earlier and progress faster. Scientists believe other genes besides NOTCH3 probably influence disease severity, and research is ongoing to identify these genes. This variability means that while you inherit the NOTCH3 mutation, other genetic and lifestyle factors affect how severely the disease manifests.[19]

How can I tell the difference between a migraine aura and a mini-stroke in CADASIL?

This can be challenging, but there are some helpful clues. Migraine auras typically spread gradually from one body part to another (like starting in the face and moving to the arm), while stroke symptoms usually affect multiple areas simultaneously. Migraine symptoms are often “positive” sensations like tingling, while stroke symptoms are typically “negative” like inability to feel or move. Migraines usually come with headache, nausea, and sensitivity to light, whereas strokes in CADASIL don’t typically cause visual disturbances or word-finding difficulties. When in doubt, seek medical evaluation.[19]

Should I take aspirin if I have CADASIL but haven’t had a stroke yet?

This is a complex decision that should be made with your doctor. Aspirin reduces stroke risk by about 20% in people who’ve already had strokes, so most doctors recommend it for CADASIL patients who’ve experienced stroke or TIA. However, for people with CADASIL who haven’t had strokes, there’s no clear evidence of benefit, and aspirin increases bleeding risk because CADASIL makes brain blood vessels fragile. Some patients start taking aspirin when they reach their 40s or 50s, but this should be an individualized decision based on your specific situation.[14][19]

Can my children inherit CADASIL from me?

CADASIL follows an autosomal dominant inheritance pattern, which means if you have the condition, each of your children has a 50% (1 in 2) chance of inheriting the mutated NOTCH3 gene. Both sons and daughters have equal risk. However, even if a child inherits the mutation, the severity of their symptoms may be very different from yours due to other genetic and environmental factors. Genetic counseling can help families understand these risks and make informed decisions about family planning.[5]

Is there any treatment that can slow down or stop CADASIL?

Currently, there is no cure or medication that can stop the underlying blood vessel damage caused by CADASIL. However, managing stroke risk factors can significantly affect disease progression. Controlling high blood pressure, cholesterol, and blood sugar is crucial. Quitting smoking is extremely important, as smoking worsens CADASIL progression. Staying physically active, maintaining a healthy weight, and treating depression can improve quality of life and possibly slow functional decline. Researchers are actively studying potential treatments, but none have been proven effective yet.[1][14]

🎯 Key takeaways

  • CADASIL progresses slowly over decades, with most people developing cognitive impairment or dementia by age 65, but disease severity varies dramatically even within families
  • Controlling modifiable risk factors like smoking and high blood pressure can significantly influence when symptoms appear and how quickly the disease progresses
  • The disease affects far more than the brain — it impacts employment, relationships, independence, and emotional well-being, requiring comprehensive support
  • Cerebral microbleeds caused by fragile blood vessels make treatment decisions about blood thinners complex and individualized
  • Depression is extremely common in CADASIL and requires active treatment, as mental health significantly affects quality of life and functional abilities
  • Recent research suggests CADASIL may be much more common than previously recognized, with many people carrying mild forms that go undiagnosed
  • Families play a crucial role in supporting research participation through helping with logistics, staying informed about clinical trials, and providing emotional support
  • While there’s currently no cure, managing symptoms, adapting daily activities, and maintaining social connections can preserve quality of life despite disease progression